Abstract
Endophenotypes are heritable quantitative traits that are associated with disease liability, can be measured in both affected and unaffected individuals, and provide much greater power to localize and identify risk genes for mental illness than does affection status alone. Traditionally, endophenotypic markers for psychiatric illnesses include in vivo neuroanatomic and functional magnetic resonance imaging measurements and indices of neurocognitive abilities. However, neurocognitive and neuroimaging measures are by no means the only classes of endophenotypes that could be useful for identifying genes for mental illness. Given the advantages of endophenotype-based strategies for elucidating the genetic underpinnings of psychiatric disorders, it would seem prudent to develop a wide range of putative endophenotypes. In order for a measure to be considered a valid endophenotype, it must meet a number of criteria. Specifically, the trait must (1) have moderate to high heritability, (2) be associated with the illness, (3) be independent of clinical state, and (4) impairment must co-segregate with the illness within a family, with non-affected family members showing impairment relative to the general population. While each of these criteria is critical, the heritability and co-segregation requirements are really what differentiate an endophenotype from a simple biomarker. At this time, one requires an experimental design that includes families to demonstrate both heritability and co-segregation. The assertion that novel endophenotypes can not be fully established without family data does not preclude work in unrelated individuals, rather that unrelated samples will only be able to nominate potential candidate endophenotypes that subsequently need to be confirmed in family-based experiments.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gottesman I I, Gould T D. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry, 2003, 160: 636–645
Blangero J, Williams J T, Almasy L. Novel family-based approaches to genetic risk in thrombosis. J Thromb Haemost, 2003, 1: 1391–1397
Lenox R H, Gould T D, Manji H K. Endophenotypes in bipolar disorder. Am J Med Genet, 2002, 114: 391–406
Bearden C, Freimer N. Endophenotypes for psychiatric disorders: Ready for primetime? Trends Genet, 2006, 22: 306–313
Gould T, Gottesman I. Psychiatric endophenotypes and the development of valid animal models. Genes Brain Behav, 2006, 5: 113–119
Nestler E, Barrot M, DiLeone R J, et al. Neurobiology of depression. Neuron, 2002, 34: 13–25
Glahn D, Almasy L, Blangero J, et al. Adjudicating neurocognitive endophenotypes for schizophrenia. Am J Med Genet B Neuropsychiatr Genet, 2007, 144B: 242–249
Glahn D, Almsay L, Barguil M, et al. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Arch Gen Psychiatry, 2010, 67: 168–177
Meyer-Lindenberg A. Neural connectivity as an intermediate pheno-type: Brain networks under genetic control. Hum Brain Mapp, 2009, 30: 1938–1946
Winkler A, Kochunov P, Blangero J, et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage, 2010, 53: 1135–1146
Glahn D, Winkler A, Kochunov P, et al. Genetic control over the resting brain. Proc Natl Acad Sci USA, 2010, 107: 1223–1228
Glahn D, Thompson P, Blangero J. Neuroimaging endophenotypes: Strategies for finding genes influencing brain structure and function. Hum Brain Mapp, 2007, 28: 488–501
Harris J M, Whalley H, Yates S, et al. Abnormal cortical folding in high-risk individuals: A predictor of the development of schizophrenia? Biol Psychiatry, 2004, 56: 182–189
Moffat S D, Szekely C A, Zonderman A B, et al. Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype. Neurology, 2000, 55: 134–136
Fleisher A, Grundman M, Jack C R, et al. Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment. Arch Neurol, 2005, 62: 953–957
Hill S, De Bellis M, Keshavan M, et al. Right amygdala volume in adolescent and young adult offspring from families at high risk for developing alcoholism. Biol Psychiatry, 2001, 49: 894–905
McDonald C, Bullmore E, Sham P, et al. Association of genetic risks for schizophrenia and bipolar disorder with specific and generic brain structural endophenotypes. Arch Gen Psychiatry, 2004, 61: 974–984
Cannon T D, Thompson P M, Van Erp T, et al. Cortex mapping reveals regionally specific patterns of genetic and disease-specific gray-matter deficits in twins discordant for schizophrenia. Proc Natl Acad Sci USA, 2002, 99: 3228–3233
Greenwood P, Parasuraman R. Normal genetic variation, cognition, and aging. Behav Cogn Neurosci Rev, 2003, 2: 278–306
Weiser M, Reichenberg A, Kravitz E, et al. Subtle cognitive dysfunction in nonaffected siblings of individuals affected by nonpsychotic disorders. Biol Psychiatry, 2008, 63: 602–608
Greenwood T, Braff D, Light G, et al. Initial heritability analyses of endophenotypic measures for schizophrenia: The consortium on the genetics of schizophrenia. Arch Gen Psychiatry, 2007, 64: 1242–1250
Freedman R, Adler L E, Leonard S. Alternative phenotypes for the complex genetics of schizophrenia. Biol Psychiatry, 1999, 45: 551–558
Olincy A, Braff D, Adler L, et al. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: Results from the consortium on genetics of schizophrenia. Schizophr Res, 2010, 119: 175–182
Turetsky B I, Greenwood T, Olincy A, et al. Abnormal auditory N100 amplitude: A heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry, 2008, 64: 1051–1059
Turetsky B I, Kohler C, Gur R, et al. Olfactory physiological impairment in first-degree relatives of schizophrenia patients. Schizophr Res, 2008, 102: 220–229
Kurian S M, Le-Niculescu H, Patel S D, et al. Identification of blood biomarkers for psychosis using convergent functional genomics. Mol Psychiatry, 2011, 16: 37–58
Gershon E, Goldin L. Clinical methods in psychiatric genetics. I. Robustness of genetic marker investigative strategies. Acta Psychiatr Scand, 1986, 74: 113–118
Leboyer M, Bellivier F, Jouvent R, et al. Psychiatric genetics: Search for phenotypes. Trends Neurosci, 1998, 21: 102–105
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Glahn, D.C., Blangero, J. Why endophenotype development requires families. Chin. Sci. Bull. 56, 3382–3384 (2011). https://doi.org/10.1007/s11434-011-4740-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-011-4740-4